While we did not achieve stastistical significance for any genes in the primary pancreatic tumors and lung metastatic lesions, SLC2A1 (GLUT1) demonstrated robust overexpression in most other metastatic lesions (less than 0.05 FDR corrected p values and over 2 fold changes; Table S1). The gene discussed is SLC2A1; the disease is pancreatic neoplasm.